1 2

Semaglutide

Semaglutide

Dual-Chamber Pen

Semaglutide Peptide Pen contains a long-acting analogue of GLP-1, a hormone involved in blood sugar regulation, appetite and energy balance. Clinical studies of semaglutide have reported significant effects on body weight and blood sugar control, making it one of the most extensively studied compounds in GLP-1 research.

Its molecular structure is designed to remain active longer than natural GLP-1, with modifications that slow enzymatic breakdown and enable reversible albumin binding.

PCP’s proprietary Dual-Chamber Technology keeps the lyophilised peptide separate from the sterile diluent until activation.

For laboratory research use only. Not intended for human or veterinary use.

Strength
€84,95 EUR
€84,95 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Fast, Tracked Shipping
Secure Checkout
COA Available With Lot
Expert Support
Product Details

The Semaglutide Dual-Chamber Research Pen is supplied as a complete, preloaded system containing lyophilised Semaglutide and sterile diluent in two physically separated chambers. The components remain unmixed throughout storage and transport and are combined only when the pen is activated for laboratory preparation.

Each strength is clearly identified and presented in protective packaging for straightforward product selection, handling and storage within qualified research environments.

Product highlights:

  • Proprietary dual-chamber configuration
  • Lyophilised Semaglutide and sterile diluent contained separately
  • Components remain unmixed until activation
  • Available in 10 mg and 20 mg strengths
  • Provides 100 dial units in total
  • One complete dual-chamber research pen
  • Five 32G × 4 mm needle tips included
  • Protective packaging for storage and transport
  • Certificate of Analysis (COA) available

Technical specifications, storage conditions and handling guidance are provided separately to support accurate product identification and responsible laboratory use.

Technical Specifications
Intended Use
For laboratory research use only. Not for human or veterinary use.
Shipping Condition
Securely packaged for transport with tracked delivery.
Storage Temperature
Unopened/unmixed: store refrigerated at 2–8°C. After mixing: store refrigerated at 2–8°C. Do not freeze. Protect from light.
Presentation
One pre-filled double-chamber research pen containing unmixed components, supplied with three 32G × 4 mm needle tips
Form
Lyophilized peptide powder and diluent maintained in separate chambers
Compound Identity
Compound: Semaglutide

Compound type: Synthetic peptide analogue of human glucagon-like peptide-1 (GLP-1)

Research classification: Selective GLP-1 receptor agonist investigated in connection with receptor pharmacology, endocrine signalling, glucose-dependent pathways and metabolic regulation

Refer to the applicable product and batch documentation for verified analytical and chemical identity information.
Pen Specifications

Each pen contains a 1 mL cartridge. The amount represented by one dial unit depends on the selected pen strength. The tables below show the corresponding values for each available strength.

Pen Specifications
Pen strength Cartridge 1 dial unit
10 mg 1 mL 0.1 mg
20 mg 1 mL 0.2 mg
40 mg 1 mL 0.4 mg

Dial-Unit Conversion Reference

The table shows the amount represented by each listed dial setting for the available pen strengths.

Dial-unit reference by pen strength
Dial units 10 mg 20 mg 40 mg
1 0.1 mg 0.2 mg 0.4 mg
4 0.4 mg 0.8 mg 1.6 mg
5 0.5 mg 1.0 mg 2.0 mg
10 1.0 mg 2.0 mg 4.0 mg
20 2.0 mg 4.0 mg 8.0 mg
40 4.0 mg 8.0 mg 16.0 mg

Research-use information: Dial-unit values are provided solely for product identification, quantitative laboratory planning and documentation. They are not administration or clinical dosing instructions.

Storage & Handling

Recommended storage: Unopened/unmixed: store refrigerated at 2–8°C. After mixing: store refrigerated at 2–8°C. Do not freeze. Protect from light.

Protect the product from light and moisture and minimise unnecessary exposure to room temperature.

Complete storage and handling guidance is provided in the product information section below.

Research Use Only

All Pencell Peptide (PCP) products are supplied exclusively for laboratory research use by qualified professionals. They are not intended for human or veterinary use, consumption, personal use, medical, therapeutic, or diagnostic applications. Customers are responsible for lawful purchase, storage, handling, use, and disposal in accordance with applicable regulations and approved laboratory procedures.

View full details

Protected by Design

Peptide and diluent remain separate until preparation

≥98% Purity

HPLC verified for research grade quality

Controlled Conditions

Prepared with a focus on consistency and research quality

Certificate of Analysis

Provided with Every Lot

Scientific Overview

Scientific Background

Semaglutide is a synthetic peptide built from a specific sequence of amino acids. Its structure is based on the naturally occurring hormone GLP-1, but includes targeted modifications that make the molecule more resistant to breakdown and extend its activity.

Semaglutide acts as a selective GLP-1 receptor agonist, meaning it binds to and activates the GLP-1 receptor. This receptor plays an important role in glucose regulation, insulin signalling, appetite and energy balance, making it a major target in metabolic and endocrine research.

Its molecular design is particularly important. Semaglutide contains structural modifications that reduce enzymatic degradation, together with a fatty-acid side chain that enables reversible albumin binding. These features give it a substantially longer duration of activity than native GLP-1 and allow researchers to study prolonged GLP-1 receptor signalling.

Research involving Semaglutide therefore contributes to understanding the relationship between peptide structure, receptor activity and metabolic regulation, from molecular and cellular mechanisms through to effects observed in clinical studies.

This information is provided as general scientific background for laboratory research purposes.
Research Context

Research Applications

Areas examined within controlled laboratory research.

Semaglutide is a selective GLP-1 receptor agonist that has been extensively studied for its effects on body weight, blood sugar control and metabolic health. Clinical research has reported substantial changes in these areas, making semaglutide an important compound for understanding how GLP-1 signalling influences metabolism.

Researchers continue to investigate how these effects are connected to appetite signalling, glucose regulation, insulin response and energy balance, as well as the wider biological pathways influenced by GLP-1 receptor activation.

Current areas of scientific investigation include:

  1. Endocrine Signalling

    Investigation of peptide-mediated receptor activity and its role in hormonal communication, endocrine regulation and coordination between biological systems.

  2. Metabolic Signalling

    Research into molecular pathways involved in glucose regulation, energy balance, nutrient-responsive signalling, lipid metabolism and broader metabolic processes.

  3. Peptide Structure and Function (Semaglutide)

    Investigation of how Semaglutide's amino acid sequence and molecular structure influence receptor interaction, biological activity, molecular stability and peptide function.

  4. Comparative Peptide Research (Semaglutide)

    Comparison of Semaglutide with other GLP-1 receptor agonists and related peptide compounds to improve understanding of receptor selectivity, molecular characteristics and biological activity.

  5. Cellular and Molecular Responses

    Study of downstream signalling events, cellular responses and pathway-specific biological mechanisms following receptor activation.

  6. GLP-1 Receptor Pharmacology

    Evaluation of Semaglutide's interaction with the GLP-1 receptor, including receptor binding, activation, selectivity and downstream signalling pathways that contribute to metabolic and endocrine research.

Clinical studies of Semaglutide have reported substantial effects on body weight and blood sugar control, providing researchers with important evidence of how selective GLP-1 receptor activation can influence human metabolism.

Beyond these clinical findings, research continues to examine the mechanisms behind these effects, including changes in appetite signalling, insulin response, glucose regulation and energy balance. This helps build a clearer understanding of how GLP-1 receptor activity connects molecular signalling with wider metabolic responses.

Semaglutide also remains an important model for studying how peptide structure and prolonged receptor activity can influence biological effects over time.

For laboratory research purposes only. Not intended for human or veterinary use.

Important Notice Research Use Only View complete notice

All products supplied by Pencell Peptide (PCP), including its dual-chamber peptide research pens, are intended strictly for laboratory research purposes only.

These products are not intended for human or animal consumption, medical or veterinary use, therapeutic applications, diagnostic procedures or any other clinical purpose.

Customers are responsible for complying with all applicable laws, regulations and institutional requirements governing the purchase, possession, handling, storage and use of peptide research materials.

Read the complete Research Use Only notice .